Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S. A. Tjuljandin"'
Autor:
T. A. Bogush, A. S. Popova, E. A. Dudko, E. O. Ignatova, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 7-8, Pp 40-47 (2020)
The aim of the review was systematization of the data on discordance in expression of estrogen receptors between primary and metastatic breast cancer, different metastases and repeated analyses of the same tissue. The possible reasons for the phenome
Externí odkaz:
https://doaj.org/article/4ac97a55831a4873850c4cc5d4346603
Autor:
T. A. Bogush, E. A. Dudko, A. A. Beme, E. A. Bogush, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov
Publikováno v:
Антибиотики и Химиотерапия, Vol 54, Iss 7-8, Pp 41-49 (2020)
A review of the literature data on expression of estrogen receptor alpha and beta (ERa and ERβ) in tumors different from breast cancer. The results regarding the ERa and ERβ expression frequency in non-small cell and small cell lung cancer, colorec
Externí odkaz:
https://doaj.org/article/09e4a643e7eb4886a039f420b6764d90
Autor:
T. A. Bogush, B. B. Polezhaev, E. A. Dudko, E. A. Bogush, V. Yu. Kirsanov, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov
Publikováno v:
Антибиотики и Химиотерапия, Vol 61, Iss 3-4, Pp 41-49 (2020)
Tamoxifen is the first target agent with a high-end position in breast cancer therapy till now. In recent years experimental researches revealed new biological effects of tamoxifen on tumor cells. The present study continues the theme of the review p
Externí odkaz:
https://doaj.org/article/bd1dbae81c594580bf9812df0893d230
Autor:
E V Artamonova, V A Gorbunova, N V Zhukov, L V Manzjuk, A G Manihas, P M Paltuev, V F Semiglazov, T Yu Semiglazova, M B Stenina, S A Tjuljandin, V A Chubenko
Publikováno v:
Современная онкология, Vol 16, Iss 2, Pp 12-16 (2014)
The leading oncologists' meeting was held on February 7, 2014 in Moscow. Those in attendance discussed treatment approaches ofbreast cancer, and in particular, locally-advanced and metastatic breast cancer. Participants came to the conclusion that pa
Externí odkaz:
https://doaj.org/article/8d8314f2d766496e8a66aea101011950
Autor:
T A, Bogush, B B, Polezhaev, E A, Dudko, E A, Bogush, V Yu, Kirsanov, B E, Polotsky, S A, Tjuljandin, M I, Davydov
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 61
Tamoxifen is the first target agent with a high-end position in breast cancer therapy till now. In recent years experimental researches revealed new biological effects of tamoxifen on tumor cells. The present study continues the theme of the review p
Autor:
B.E. Polotsky, Mikhail Davydov, E. A. Dudko, A. A. Beme, A. I. Kim, S. A. Tjuljandin, E. A. Bogush, T. A. Bogush
Publikováno v:
Biochemistry (Moscow). 75:1421-1427
This review considers data on expression of different types of estrogen receptors (ERα and ERβ) in in vitro cultured cells of non-small cell lung cancer and also in human and animal lung tumors. Estrogens are shown to play an important role in gene
Autor:
S A, Tjuljandin, R G, Doig, M M, Sobol, D M, Watson, W P, Sheridan, G, Morstyn, G, Mihaly, M D, Green
Publikováno v:
Cancer research. 50(16)
Epirubicin, a stereoisomer of doxorubicin, is reported to have equal antitumor activity with lower cardiac and systemic toxicity. Recently the maximum tolerated dose of this drug has been revised upwards with reported increased response rates. Howeve